100 related articles for article (PubMed ID: 23042505)
1. Galectin-3 expression in thyroid fine needle cytology (t-FNAC) uncertain cases: validation of molecular markers and technology innovation.
Papale F; Cafiero G; Grimaldi A; Marino G; Rosso F; Mian C; Barollo S; Pennelli G; Sorrenti S; De Antoni E; Barbarisi A
J Cell Physiol; 2013 May; 228(5):968-74. PubMed ID: 23042505
[TBL] [Abstract][Full Text] [Related]
2. Utility of galectin 3 expression in thyroid aspirates as a diagnostic marker in differentiating benign from malignant thyroid neoplasms.
Aron M; Kapila K; Verma K
Indian J Pathol Microbiol; 2006 Jul; 49(3):376-80. PubMed ID: 17001889
[TBL] [Abstract][Full Text] [Related]
3. Fine needle aspiration cytology in diagnosis and management of thyroid disease.
Bajaj Y; De M; Thompson A
J Laryngol Otol; 2006 Jun; 120(6):467-9. PubMed ID: 16526971
[TBL] [Abstract][Full Text] [Related]
4. Immunostaining of galectin-3 and CD44v6 using fine-needle aspiration for distinguishing follicular carcinoma from adenoma.
Maruta J; Hashimoto H; Yamashita H; Yamashita H; Noguchi S
Diagn Cytopathol; 2004 Dec; 31(6):392-6. PubMed ID: 15540177
[TBL] [Abstract][Full Text] [Related]
5. [Fine-needle aspiration biopsy of the thyroid nodule: uses and limitations].
Hayashi N; Kitaoka M
Nihon Rinsho; 2007 Nov; 65(11):2003-7. PubMed ID: 18018562
[TBL] [Abstract][Full Text] [Related]
6. [Expression and clinical significance of galectin-3 in well-differentiated thyroid carcinoma].
Ouyang D; Chen FJ; Wei MW; Yang AK; Chen ZQ; Li QL; Chen YF
Ai Zheng; 2005 Nov; 24(11):1367-71. PubMed ID: 16552965
[TBL] [Abstract][Full Text] [Related]
7. Characterization of thyroid 'follicular neoplasms' in fine-needle aspiration cytological specimens using a panel of immunohistochemical markers: a proposal for clinical application.
Saggiorato E; De Pompa R; Volante M; Cappia S; Arecco F; Dei Tos AP; Orlandi F; Papotti M
Endocr Relat Cancer; 2005 Jun; 12(2):305-17. PubMed ID: 15947105
[TBL] [Abstract][Full Text] [Related]
8. Immunogold labelling in environmental scanning electron microscopy: applicative features for complementary cytological interpretation.
Cafiero G; Papale F; Grimaldi A; Rosso F; Barbarisi M; Tortora C; Marino G; Barbarisi A
J Microsc; 2011 Jan; 241(1):83-93. PubMed ID: 21118204
[TBL] [Abstract][Full Text] [Related]
9. Galectin-3 does not reliably distinguish benign from malignant thyroid neoplasms.
Mehrotra P; Okpokam A; Bouhaidar R; Johnson SJ; Wilson JA; Davies BR; Lennard TW
Histopathology; 2004 Nov; 45(5):493-500. PubMed ID: 15500653
[TBL] [Abstract][Full Text] [Related]
10. Expression of Galectin-3 and Galectin-7 in thyroid malignancy as potential diagnostic indicators.
Than TH; Swethadri GK; Wong J; Ahmad T; Jamil D; Maganlal RK; Hamdi MM; Abdullah MS
Singapore Med J; 2008 Apr; 49(4):333-8. PubMed ID: 18418527
[TBL] [Abstract][Full Text] [Related]
11. An updated audit of fine needle aspiration cytology procedure of solitary thyroid nodule.
Bukhari MH; Niazi S; Hanif G; Qureshi SS; Munir M; Hasan M; Naeem S
Diagn Cytopathol; 2008 Feb; 36(2):104-12. PubMed ID: 18181183
[TBL] [Abstract][Full Text] [Related]
12. [A comparative study of cytological and histological studies of the thyroid gland].
Emmrich P; Gauer G; Gauer J; Mättig H; Rosenkranz M
Zentralbl Chir; 2001 Apr; 126(4):267-72. PubMed ID: 11370387
[TBL] [Abstract][Full Text] [Related]
13. Detection of high mobility group I HMGI(Y) protein in the diagnosis of thyroid tumors: HMGI(Y) expression represents a potential diagnostic indicator of carcinoma.
Chiappetta G; Tallini G; De Biasio MC; Manfioletti G; Martinez-Tello FJ; Pentimalli F; de Nigris F; Mastro A; Botti G; Fedele M; Berger N; Santoro M; Giancotti V; Fusco A
Cancer Res; 1998 Sep; 58(18):4193-8. PubMed ID: 9751634
[TBL] [Abstract][Full Text] [Related]
14. Divide and rule: cytodiagnosis of thyroid lesions using pattern analysis: a study of 233 cases.
MuddeGowda PH; Lingegowda J; Natesan R; Kurpad R
Diagn Cytopathol; 2011 Dec; 39(12):888-95. PubMed ID: 22081525
[TBL] [Abstract][Full Text] [Related]
15. Role of pro-angiogenic marker galectin-3 in follicular neoplasms of thyroid.
Manivannan P; Siddaraju N; Jatiya L; Verma SK
Indian J Biochem Biophys; 2012 Oct; 49(5):392-4. PubMed ID: 23259327
[TBL] [Abstract][Full Text] [Related]
16. Combined analysis of galectin-3 and BRAFV600E improves the accuracy of fine-needle aspiration biopsy with cytological findings suspicious for papillary thyroid carcinoma.
Sapio MR; Guerra A; Posca D; Limone PP; Deandrea M; Motta M; Troncone G; Caleo A; Vallefuoco P; Rossi G; Fenzi G; Vitale M
Endocr Relat Cancer; 2007 Dec; 14(4):1089-97. PubMed ID: 18045960
[TBL] [Abstract][Full Text] [Related]
17. [Galectin-3 in differential diagnosis and prognosis of follicular tumors of the thyroid gland].
Iushkov PV; Antonova SS; Bartolazzi A
Arkh Patol; 2004; 66(6):39-42. PubMed ID: 15648166
[TBL] [Abstract][Full Text] [Related]
18. Use and accuracy of fine-needle aspiration cytology in histologically proven thyroid carcinoma: an audit using a national nathology database.
Giard RW; Hermans J
Cancer; 2000 Dec; 90(6):330-4. PubMed ID: 11156515
[TBL] [Abstract][Full Text] [Related]
19. Galectin-1 is a diagnostic marker involved in thyroid cancer progression.
Arcolia V; Journe F; Wattier A; Leteurtre E; Renaud F; Gabius HJ; Remmelink M; Decaestecker C; Rodriguez A; Boutry S; Laurent S; Saussez S
Int J Oncol; 2017 Sep; 51(3):760-770. PubMed ID: 28677745
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic pitfalls in the evaluation of fine needle aspiration cytology of the thyroid: correlation with histopathology in 260 cases.
Haberal AN; Toru S; Ozen O; Arat Z; Bilezikçi B
Cytopathology; 2009 Apr; 20(2):103-8. PubMed ID: 18713250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
